Card image cap

Nydia Velázquez's Public Statements on Issue: Drugs

Office:

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Date Title
09/22/2023 Nadler, Blumenauer, Lee, Jackson Lee and Velázquez Reintroduce Comprehensive Marijuana Reform Legislation
12/07/2021 Letter to Hon. Chuck Schumer, Majority Leader US Senate - Keep Affordable Insulin Measures in Build Back Better Act
05/28/2021 Nadler, Blumenauer, Lee, Jackson Lee, Jeffries, and Velázquez Reintroduce Comprehensive Marijuana Reform Legislation
04/20/2021 Velázquez, Evans, and Golden Look to Spark Growth by Extending SBA Lending to Small Cannabis Businesses
04/19/2021 Secure and Fair Enforcement Banking Act of 2021
03/22/2021 Velázquez Reintroduces Bill to Help Businesses in the Cannabis Sector Obtain Insurance
02/18/2021 Letter to Joe Biden, President of the United States - Blumenauer and Lee Urge President Biden to Pardon Federal Cannabis Offenses
07/29/2019 Velázquez Bill Would Help Cannabis Firms Secure Insurance
06/19/2019 Committee Holds Hearing on Role of Small Businesses in Cannabis Sector
06/19/2019 Hearing of the House Small Business Committee - Opening Statement of Rep. Velazquez, Hearing on Unlocking Potential: Small Businesses in the Cannabis Industry
06/11/2019 Letter to Chris Pilkerton, Acting Administrator and General Counsel of the Small Business Administration - Golden, Velázquez Press SBA to Revise Financial Assistance Policy for Marijuana-Related Businesses
07/31/2018 Letter to Dr. Robert R. Redfield, Director of the Centers for Disease Control and Prevention - Linda Sánchez Leads Bipartisan Letter to Help Secure CDC Funding for Major U.S. Cities to Fight Opioid Crisis
05/21/2018 Velázquez Response to K2 Overdoses in Brooklyn
05/15/2018 Velázquez on News that BK and Manhattan DAs are Ceasing Marijuana Prosecutions
04/19/2018 Letter to the Hon. John Culberson, House Subcommittee on Commerce, Justice, Science, and Related Agencies Chairman, and the Hon. José Serrano, Subcommittee Ranking Member - Effectively Address Opioid Crisis In Fiscal Year 2019 Spending Bill
06/19/2017 Velázquez Bill Dedicates Federal Funds to Target "K2" Drug
07/25/2016 Letter to Tom Frieden, MD, MPH, Director for Centers for Disease Control and Prevention - Velázquez Calls for Federal Effort on K2 Drug
09/15/2010 Recommendation Of Changes In Law That Help Achieve Deficit Reduction By Reducing Waste, Fraud, Abuse, And Mismanagement, Promoting Efficiency And Reform Of Government; And Controlling Spending Within Government Programs, Pursuant To H. Res. 1493
02/04/2009 Reauthorization of SCHIP Program Expands Reach to Include Nearly 1 Million New York Children
arrow_upward